DS
SRTA

David Shaw’s Strata Critical Medical Inc SRTA Stock Holding History

David Shaw’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,217
Closed -$102K – 4601
2025
Q3 		$102K Buy
+20,217
New +$89.3K ﹤0.01% 4347

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

David Shaw's SRTA Position: Q4 2025 in Review

David Shaw sold out of Strata Critical Medical Inc (SRTA) in Q4 2025, closing a stake of 20,217 shares — an estimated $102K sold.

David Shaw first reported a position in SRTA in Q3 2025 and held it in 1 quarter. The position peaked at $102K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q4 2025.

  • David Shaw reported no remaining Strata Critical Medical Inc position as of Q4 2025 after selling out during the quarter.
  • David Shaw sold 20,217 Strata Critical Medical Inc shares in Q4 2025, an estimated $102K.
  • David Shaw first reported a position in Strata Critical Medical Inc in Q3 2025 and held it in 1 quarter.
  • David Shaw's Strata Critical Medical Inc position peaked at $102K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.